Can Probiotics be Used in the Prevention of Recurrent UTI in Paediatric Neurogenic Bladder
A Clinical Trial to Determine the Extent to Which Probiotic Therapy Reduces Side Effects of Antibiotic Prophylaxis in Pediatric Neurogenic Bladder Patients With a History of Recurrent Urinary Tract Infections
Sponsor: Canadian Urological Association
This PHASE1/PHASE2 trial investigates Urinary Tract Infection and is currently ongoing. Canadian Urological Association leads this study, which shows 8 recorded versions since 2015 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE1/PHASE2
Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Jan 2024 — Jul 2024 [monthly]
Unknown Status PHASE1_PHASE2
Status: Recruiting → Unknown Status
-
Oct 2021 — Jan 2024 [monthly]
Recruiting PHASE1_PHASE2
Status: Unknown Status → Recruiting
-
Jan 2021 — Oct 2021 [monthly]
Unknown Status PHASE1_PHASE2
▶ Show 3 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Unknown Status PHASE1_PHASE2
-
May 2017 — Jun 2018 [monthly]
Unknown Status PHASE1_PHASE2
Status: Not Yet Recruiting → Unknown Status
-
Jan 2017 — May 2017 [monthly]
Not Yet Recruiting PHASE1_PHASE2
First recorded
Jan 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Canadian Urological Association
- London Health Sciences Centre
For direct contact, visit the study record on ClinicalTrials.gov .